Comparison Between Tramadol Hcl and Other Analgesics in the Treatment of Renal Colic
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00310908 |
Recruitment Status :
Completed
First Posted : April 5, 2006
Last Update Posted : February 17, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Renal Calculus | Drug: Tramadol Hcl | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 100 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Efficacy of Tramadol Hcl in the Treatment of Renal Colic |
Study Start Date : | September 2006 |
Actual Primary Completion Date : | February 2009 |
Actual Study Completion Date : | February 2009 |

- Drug: Tramadol Hcl
Active Comparator
- Pain improvement according to VAS score at 30, 60 and 120 minutes(Stage I) [ Time Frame: 30, 60, 120 minutes ]
- Need for rescue medication at 30 minutes (Stage I) [ Time Frame: 30 minutes ]
- Pain improvement according to VAS score at 24 and 48 hrs (Stage II) [ Time Frame: 24 and 48 hrs ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients with clinical diagnosis of acute renal colic (Stage I)
- Patients with diagnosed renal colic who might need prevention of pain and are able to swallow medicines (Stage II)
Exclusion Criteria:
- Patients with known hypersensitivity to the study drugs
- Pregnancy or lactation
- Known renal failure or hepatic disease
- Concommitant drug use which could adversely affect patient's outcome (oral anticoagulant, MAO inhibitors)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00310908
Israel | |
Hadassah Medical Organization | |
Jerusalem, Israel, 12000 |
Principal Investigator: | Ruth Stalnikowicz, MD | Hadassah Medical Organization |
Responsible Party: | Ruth Stalnikowicz, Hadassah Medical Organization |
ClinicalTrials.gov Identifier: | NCT00310908 |
Other Study ID Numbers: |
1234567-HMO-CTIL |
First Posted: | April 5, 2006 Key Record Dates |
Last Update Posted: | February 17, 2009 |
Last Verified: | September 2006 |
Renal Colic Calculi Treatment |
Kidney Calculi Nephrolithiasis Calculi Renal Colic Pathological Conditions, Anatomical Pain Neurologic Manifestations Kidney Diseases Urologic Diseases Urolithiasis |
Urinary Calculi Tramadol Analgesics, Opioid Narcotics Central Nervous System Depressants Physiological Effects of Drugs Analgesics Sensory System Agents Peripheral Nervous System Agents |